NCT01967550View on ClinicalTrials.gov

Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

PHASE3CompletedINTERVENTIONAL

Enrollment

304

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Osteoarthritis, Knee

Interventions

DRUG

diclofenac diethylamine, DDEA 2.32% gel

DRUG

Placebo

Trial Locations (5)

Unknown

Bad Hersfeld

Berlin

Hamburg

Munich

Stockach

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY